Objective To study the clinical significance of the novel tumor marker--CYFRA21-1 in
patients with esophageal cancer. Methods The CYFRA21-1 level in serum of 84 patients …

BACKGROUND: CYFRA 21-1 has been reported as a useful tumor marker for esophageal
carcinoma, but little information was reported about the clinicopathologic importance of …

Objective To evaluate the clinical usefulness of CYFRA21-1 as a serum tumor marker in
diagnosis, evaluation of clinical status and prognosis of patients with non-small-cell lung …

Objective To set the serum cut-off value of CYFRA21-1 in lung cancer patients in china, and
to evaluate the clinical usefulness of CYFRA21-1 as a new tumor marker of lung cancer …

From January 2018 to May 2018, 108 patients with thoracic esophageal cancer underwent
esophagectomy with two-to three-field lymph node dissection. Serum cytokeratin 19 …

Serum CYFRA21-1 levels were studied in 127 cases of colorectal cancer. The positive rates
for serum CYFRA21-1 were 34.6% in primary colorectal cancer. There was a significant …

BACKGROUND CYFRA 21‐1 measures soluble cytokeratin‐19 fragments in serum and is a
useful marker for lung carcinoma, especially squamous cell carcinoma (SCC). The authors …

The patient was a 75-year-old man whose complaint was back pain and appetite loss. He
was diagnosed with unresectable advanced gastric cancer due to multiple liver metastases …

BACKGROUND While there are reports that CYFRA 21‐1 is a useful tumor marker, to our
knowledge the clinical utility of this marker to detect recurrences for squamous cell …

This study was aimed to evaluate the clinical values of single markers and combination in
the diagnosis, short-term efficacy and recurrence risk assessment of esophageal squamous …